255 related articles for article (PubMed ID: 33311639)
1. Nasopharyngeal carcinoma MHC region deep sequencing identifies HLA and novel non-HLA TRIM31 and TRIM39 loci.
Ning L; Ko JM; Yu VZ; Ng HY; Chan CK; Tao L; Lam SY; Leong MM; Ngan RK; Kwong DL; Lee AW; Ng WT; Cheng A; Tung S; Lee VH; Lam KO; Kwan CK; Li WS; Yau S; Bei JX; Lung ML
Commun Biol; 2020 Dec; 3(1):759. PubMed ID: 33311639
[TBL] [Abstract][Full Text] [Related]
2. Emerging Roles of MHC Class I Region-Encoded E3 Ubiquitin Ligases in Innate Immunity.
Jia X; Zhao C; Zhao W
Front Immunol; 2021; 12():687102. PubMed ID: 34177938
[TBL] [Abstract][Full Text] [Related]
3. Fine-mapping of HLA class I and class II genes identified two independent novel variants associated with nasopharyngeal carcinoma susceptibility.
Wang TM; Zhou T; He YQ; Xue WQ; Zhang JB; Zheng XH; Li XZ; Zhang SD; Zeng YX; Jia WH
Cancer Med; 2018 Dec; 7(12):6308-6316. PubMed ID: 30378292
[TBL] [Abstract][Full Text] [Related]
4. A regulatory mutant on TRIM26 conferring the risk of nasopharyngeal carcinoma by inducing low immune response.
Lyu XM; Zhu XW; Zhao M; Zuo XB; Huang ZX; Liu X; Jiang T; Yang XX; Li X; Long XB; Wang JG; Li JB; Han MY; Wang S; Liu TF; Zhang B; Sun T; Cheng Z; Qiu MC; Dong L; Zheng L; Zhang LC; Wang JH; Wei GG; Yao K; Wang Q; Zheng HF; Li X
Cancer Med; 2018 Aug; 7(8):3848-3861. PubMed ID: 29956500
[TBL] [Abstract][Full Text] [Related]
5. Multiple low-frequency and rare HLA-B allelic variants are associated with reduced risk in 1,105 nasopharyngeal carcinoma patients in Hunan province, southern China.
Tian W; Zhu F; Cai J; Li L; Jin H; Wang W
Int J Cancer; 2020 Sep; 147(5):1397-1404. PubMed ID: 32212153
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3.
Tse KP; Su WH; Chang KP; Tsang NM; Yu CJ; Tang P; See LC; Hsueh C; Yang ML; Hao SP; Li HY; Wang MH; Liao LP; Chen LC; Lin SR; Jorgensen TJ; Chang YS; Shugart YY
Am J Hum Genet; 2009 Aug; 85(2):194-203. PubMed ID: 19664746
[TBL] [Abstract][Full Text] [Related]
7. The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove.
Tang M; Lautenberger JA; Gao X; Sezgin E; Hendrickson SL; Troyer JL; David VA; Guan L; McIntosh CE; Guo X; Zheng Y; Liao J; Deng H; Malasky M; Kessing B; Winkler CA; Carrington M; Dé The G; Zeng Y; O'Brien SJ
PLoS Genet; 2012; 8(11):e1003103. PubMed ID: 23209447
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of human leukocyte antigen-A (HLA-A), other non-HLA markers on chromosome 6p21 and risk of nasopharyngeal carcinoma.
Hsu WL; Tse KP; Liang S; Chien YC; Su WH; Yu KJ; Cheng YJ; Tsang NM; Hsu MM; Chang KP; Chen IH; Chen TI; Yang CS; Goldstein AM; Chen CJ; Chang YS; Hildesheim A
PLoS One; 2012; 7(8):e42767. PubMed ID: 22880099
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Rare and Common Variants from Suspected Familial or Sporadic Nasopharyngeal Carcinoma (NPC) Susceptibility Genes in Sporadic NPC.
Liu Z; Goldstein AM; Hsu WL; Yu KJ; Chien YC; Ko JY; Jian JJ; Tsou YA; Leu YS; Liao LJ; Chang YL; Wang CP; Wu JS; Hua CH; Lee JC; Yang TL; Hsiao CK; Wu MS; Tsai MH; Huang KK; Yu K; Jones K; Zhu B; Yeager M; Yu G; Lou PJ; Chen CJ; Hildesheim A;
Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1682-1686. PubMed ID: 31270100
[TBL] [Abstract][Full Text] [Related]
10. Association of HLA-G polymorphisms with nasopharyngeal carcinoma risk and clinical outcome.
Ghandri N; Gabbouj S; Farhat K; Bouaouina N; Abdelaziz H; Nouri A; Chouchane L; Hassen E
Hum Immunol; 2011 Feb; 72(2):150-8. PubMed ID: 20969909
[TBL] [Abstract][Full Text] [Related]
11. Lack of association between human leukocyte antigen-E alleles and nasopharyngeal carcinoma in Tunisians.
Hassen E; Ghedira R; Ghandri N; Farhat K; Gabbouj S; Bouaouina N; Abdelaziz H; Nouri A; Chouchane L
DNA Cell Biol; 2011 Aug; 30(8):603-9. PubMed ID: 21332388
[TBL] [Abstract][Full Text] [Related]
12. Fine mapping of eight psoriasis susceptibility loci.
Das S; Stuart PE; Ding J; Tejasvi T; Li Y; Tsoi LC; Chandran V; Fischer J; Helms C; Duffin KC; Voorhees JJ; Bowcock AM; Krueger GG; Lathrop GM; Nair RP; Rahman P; Abecasis GR; Gladman D; Elder JT
Eur J Hum Genet; 2015 Jun; 23(6):844-53. PubMed ID: 25182136
[TBL] [Abstract][Full Text] [Related]
13. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.
Chao MJ; Barnardo MC; Lui GZ; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Sadovnick AD; Ebers GC
Hum Mol Genet; 2007 Aug; 16(16):1951-8. PubMed ID: 17584771
[TBL] [Abstract][Full Text] [Related]
14. The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III-class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy.
Shichi D; Kikkawa EF; Ota M; Katsuyama Y; Kimura A; Matsumori A; Kulski JK; Naruse TK; Inoko H
Tissue Antigens; 2005 Sep; 66(3):200-8. PubMed ID: 16101831
[TBL] [Abstract][Full Text] [Related]
15. Genetic fixity in the human major histocompatibility complex and block size diversity in the class I region including HLA-E.
Romero V; Larsen CE; Duke-Cohan JS; Fox EA; Romero T; Clavijo OP; Fici DA; Husain Z; Almeciga I; Alford DR; Awdeh ZL; Zuñiga J; El-Dahdah L; Alper CA; Yunis EJ
BMC Genet; 2007 Apr; 8():14. PubMed ID: 17430593
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide association study identifies new susceptibility loci for cutaneous lupus erythematosus.
Kunz M; König IR; Schillert A; Kruppa J; Ziegler A; Grallert H; Müller-Nurasyid M; Lieb W; Franke A; Ranki A; Panelius J; Koskenmies S; Hasan T; Kere J; Rönn AC; Simon JC; Schmidt E; Wenzel J; Tüting T; Landsberg J; Zeller T; Blankenberg S; Gläser R; Patsinakidis N; Kuhn A; Ibrahim SM
Exp Dermatol; 2015 Jul; 24(7):510-5. PubMed ID: 25827949
[TBL] [Abstract][Full Text] [Related]
17. A systematic investigation of the contribution of genetic variation within the MHC region to HPV seropositivity.
Chen D; Gaborieau V; Zhao Y; Chabrier A; Wang H; Waterboer T; Zaridze D; Lissowska J; Rudnai P; Fabianova E; Bencko V; Janout V; Foretova L; Mates IN; Szeszenia-Dabrowska N; Boffetta P; Pawlita M; Lathrop M; Gyllensten U; Brennan P; McKay JD
Hum Mol Genet; 2015 May; 24(9):2681-8. PubMed ID: 25616963
[TBL] [Abstract][Full Text] [Related]
18. Haplotype-dependent HLA susceptibility to nasopharyngeal carcinoma in a Southern Chinese population.
Tang M; Zeng Y; Poisson A; Marti D; Guan L; Zheng Y; Deng H; Liao J; Guo X; Sun S; Nelson G; de Thé G; Winkler CA; O'Brien SJ; Carrington M; Gao X
Genes Immun; 2010 Jun; 11(4):334-42. PubMed ID: 20072141
[TBL] [Abstract][Full Text] [Related]
19. HLA-E polymorphism in patients with nasopharyngeal carcinoma.
Hirankarn N; Kimkong I; Mutirangura A
Tissue Antigens; 2004 Nov; 64(5):588-92. PubMed ID: 15496202
[TBL] [Abstract][Full Text] [Related]
20. A GWAS Meta-analysis and Replication Study Identifies a Novel Locus within CLPTM1L/TERT Associated with Nasopharyngeal Carcinoma in Individuals of Chinese Ancestry.
Bei JX; Su WH; Ng CC; Yu K; Chin YM; Lou PJ; Hsu WL; McKay JD; Chen CJ; Chang YS; Chen LZ; Chen MY; Cui Q; Feng FT; Feng QS; Guo YM; Jia WH; Khoo AS; Liu WS; Mo HY; Pua KC; Teo SH; Tse KP; Xia YF; Zhang H; Zhou GQ; Liu JJ; Zeng YX; Hildesheim A;
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):188-192. PubMed ID: 26545403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
